MKUltra Subproject 91

Subproject 91 funded work the surviving paperwork calls "pharmacological screening and testing," running from 1959 into the early 1960s. The grantee's name is redacted throughout. What survives is mostly money paperwork: grant statements, expense accountings, and extension memos.

Grant statements show funding of $48,000 per year. One accounting for February 1961 through January 1962 lists the full $48,000 spent on salaries, payroll taxes, employee benefits, laboratory supplies, travel, and overhead. A November 1961 memo extends the subproject six more months, starting February 1962, to fix a paperwork error in an earlier renewal.

A later memo for the record groups Subprojects 70, 91, and 135 together, saying all had the same basic research goal. It reports that accountings totaling $93,677.50 had finally been received, that funds meant for Subproject 135 were diverted to Subproject 91, and that getting any accounting at all from the grantee had been difficult. Because of the delays, the Agency recommended simply accepting the balances as shown and closing out the subprojects.